Ventyx Biosciences, Inc. (NASDAQ:VTYX) Receives Consensus Rating of “Buy” from Brokerages

Shares of Ventyx Biosciences, Inc. (NASDAQ:VTYX – Get Free Report) have been assigned an average rating of “Buy” from the eight ratings firms that are covering the company, reports. Eight equities research analysts have rated the stock with a buy rating. The average 1-year price target among analysts that have updated their coverage on […]

Leave a Reply

Your email address will not be published.

Previous post Chicago Bulls players voice frustration in a team meeting after season-opening loss: ‘It’s unacceptable’
Next post South Africa September 2023: Haval (+43.7%), Ford (+26.9%) shine in market off -4.1%